TrialTransplant international : official journal of the European Society for Organ Transplantation2022

Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series.

Željka Večerić-Haler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.